Melanoma Gene Study May Help Predict Who Will Benefit from Immunotherapy – Melanoma News Today
Melanoma News Today |
Melanoma Gene Study May Help Predict Who Will Benefit from Immunotherapy
Melanoma News Today While high mutation load in metastatic melanoma is often associated with better responses to immune checkpoint inhibitors, researchers have found that loss of certain genomic regions in metastatic melanoma can bring about resistance to such therapies. |
